Skip to content

D&A at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
$13.32M-3.2%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$82K+3.8%
CVRx, Inc. logo
CVRx, Inc.CVRX
$205K+11.4%
Stereotaxis logo
StereotaxisSTXS
$159K+1.9%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$60K+22.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$7.2M+9.1%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's D&A?
Neuronetics (STIM) reported D&A of $745K in Q1 2026.
How has Neuronetics's D&A changed year-over-year?
Neuronetics's D&A decreased by 18.2% year-over-year, from $911K to $745K.
What is the long-term trend for Neuronetics's D&A?
Over 4 years (2021 to 2025), Neuronetics's D&A has grown at a 34.5% compound annual growth rate (CAGR), from $1.06M to $3.47M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.